Dr. Laura Witte
Objectives: This study describes the use of Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) for physician assistants (PAs) and nurse practitioners (NPS) to use as a tool for the best patient modality to use in Treatment Resistant Depression (TRD).
Methods: Comparisons of both ECT and TMS began the early 2000s and is actively studied to the present day. A meta-analysis of two randomized, controlled studies and retrospective reviews were compared for efficacy in MDD treatment. Baseline score comparison of the Dutch versions of the Hamilton Depression Rating Scale (HAM-D), Beck Depression Scale (BDI-II), and the Remission from Depression Questionnaire (RDQ) were used to compare data and personalize treatment.
Results: Up to 30% of patients suffer from MDD. ECT use began in the 1960s and is used to present day with a success rate of 80-85%. TMS was introduced in 1985 also being used to the present day with an overall success rate of 50-60%. Though the success rate is significantly lagging, both PAs and NPs are recommending TMS treatment in favor of ECT due to adverse side effects and patient acceptance of treatment.
Conclusion: Providers overall are still exploring the use of both modalities, ECT and TMS. Providing up to date through various studies can help tailor the best treatment for each patient.
DeMany AL. Electroconvulsive Therapy versus Transcranial Magnetic Stimulation in Treatment of Major Depressive Disorder or Treatment Resistant Depression. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2021; 3(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.